GRN and glioblastoma: Of note, a previous study also suggests that progranulin promotes GBM cell stemness and their resistance to temozolomide, raising the intriguing possibility that targeting the progranulin pathway can provide dual benefits: attenuation of both GBM stemness and immunosuppression [46].